Statistics
Publications
1
Citations
75
H-Index
1
Active since
2013
Affiliations
China Medical University Hospital(Current)
Yi-Ling Hsieh is an author at China Medical University Hospital specializing in hepatocellular carcinoma pharmacotherapy, mek inhibitors, and oncology pharmacotherapy.
Publications per year
2013–2013
1
1
BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
Wei‐Chien Huang, Yi-Ling Hsieh, Chao-Ming Hung et al. · PLoS ONE · 2013 · 75 citations · Full text
Medicine, Oncology, Pharmacology +12
1–1 of 1